Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy

Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy

Abstract Background We investigated the prognostic predictive value of the combination of fluorodeoxyglucose (FDG)- and fluoromisonidazole (FMISO)-PET in patients with non-small cell lung carcinoma (NSCLC) treated with stereotactic body radiation therapy (SBRT). Patients and methods We prospectively...

Full description

Bibliographic Details
Main Authors: Shiro Watanabe, Tetsuya Inoue, Shozo Okamoto, Keiichi Magota, Ayumi Takayanagi, Jun Sakakibara-Konishi, Norio Katoh, Kenji Hirata, Osamu Manabe, Takuya Toyonaga, Yuji Kuge, Hiroki Shirato, Nagara Tamaki, Tohru Shiga
Format: Article
Language:English
Published: SpringerOpen 2019-12-01
Series:EJNMMI Research
Subjects:
Non-small cell lung cancer
Hypoxia
Fluoromisonidazole
Fluorodeoxyglucose
Stereotactic body radiation therapy
Online Access:https://doi.org/10.1186/s13550-019-0578-6

Internet

https://doi.org/10.1186/s13550-019-0578-6

Similar Items